Enter your email address:

Delivered by FeedBurner

Bharat Biotech recruits 23,000 volunteers for Phase III trials of its coronavirus vaccine

The Phase III human clinical trials of Covaxin began mid-November,
targeted to be done in 26,000 volunteers and it is the countrys first
and only Phase III efficacy study for a COVID-19 vaccine, and the
largest phase III efficacy trial ever conducted for any vaccine in
India, a press release from the vaccine maker said on Saturday night.



Post a Comment